期刊文献+

树突状细胞疫苗联合CpG-ODN对膀胱肿瘤细胞的免疫学效应研究 被引量:2

Immunological effects of dendritic cells plused with tumor antigen in combination with CpG oligodeoxynucleotide on bladder tumor cells in vitro
下载PDF
导出
摘要 目的探讨负载肿瘤抗原的树突状细胞(DC)疫苗联合含未甲基化胞嘧啶鸟嘌呤(CpG)序列的寡脱氧核糖核苷酸(CpG-ODN)对膀胱肿瘤细胞的免疫学效应。方法用小鼠BTT739细胞反复冻融抗原致敏培养第7天的DC,48h后分别加入CpG-ODN及肿瘤坏死因子-α(TNF-α)诱导DC成熟,制备负载肿瘤抗原的DC疫苗,灭活后用于刺激T淋巴细胞制备效应细胞(CTL),乳酸脱氢酶释放实验测定各组CTL对BTT739细胞的杀伤活性,ELISA法测定效应细胞培养上清液的干扰素-γ(IFN-γ)水平,同时检测了CTL对自体淋巴细胞的杀伤活性。结果负载肿瘤抗原的DC诱导的效应细胞分泌较高水平的IFN-γ,并对BTT739细胞具有较高的杀伤效应,CpG-ODN活化的DC疫苗诱导的效应细胞分泌IFN-γ水平及对肿瘤细胞的杀伤活性均高于TNF-α活化的DC疫苗诱导的效应细胞(P<0.01)。DC疫苗对自体淋巴细胞无明显免疫杀伤活性。结论CpG-ODN可增强负载肿瘤抗原的DC疫苗对膀胱肿瘤细胞的免疫杀伤效应,并且对自体淋巴细胞无免疫杀伤活性,为膀胱癌的免疫治疗提供了实验基础。 Objective To study the immunological effects of dendritic cells plus tumor antigen in combination with CpG oligodeoxynucleotide on bladder tumor cells in vitro. Methods After 7d culture, DCs were plused with BTT739 cell antigen and CpG- ODN,TNF-α were added. The antitumor immune responses of DCs plused with BTT739 cell antigen against BTT739 cells was assessed by determining the potent effect of cytotoxic T lymphocytes(CTL) response in vitro. The production of interferon-γ(IFN-γ) by CTL was assessed by ELISA assay. CTL-mediated cell lysis to autologous lymphocytes was also assayed. Results The production of INF 7 and specific lysis of BTT739 by effector cells stimulated by DC vaccine generated with CpG-ODN were higher than that generated with TNF-α (P〈 0. 01), whereas DC vaccine had no killing effects to antologous lymphocytes. Conclusion CpG- ODN can enhance the cytotoxicity of DC vaccine on bladder tumor cells. DC vaccine has no killing effects to autologous lymphocytes. This founding shows that the DC vaccine has characteristics of high effects and good safety and provides the experimental foundation of immunotherapy for bladder tumor.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第24期3122-3124,共3页 Chongqing medicine
关键词 膀胱肿瘤 树突状细胞 疫苗 寡脱氧核糖核苷酸 bladder tumor dendritic cell vaccine oligodeoxynucleotide
  • 相关文献

参考文献10

  • 1Krieg AM, Love-Homan L,Yi AK,et al. CpG DNA induces sustanined IL-12 expression in vivo and resistance to listeria monobytogenes challenge[J]. J Immunol, 1998, 161(5) :2428.
  • 2Pilon TS, Li W, Briggs JJ, et al. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immuno- therapy in a murine melanoma model[J]. J Immunother, 2006,29(4) :381.
  • 3聂志林,靳风烁,梁培禾,叶锦.CpG-ODN促进小鼠骨髓来源的树突状细胞成熟作用的实验研究[J].重庆医学,2008,37(2):136-138. 被引量:2
  • 4Actins H,Davis BR,Kirby JA,et al. Polarisation of a T- helper cell immune response by activation of dendritic cells with CpG-eontaining oligonucleotides: a potentiao therapeutic regime: for bladder cancer immunotherapy [J]. Br J Cancer,2003,89(12) :2312.
  • 5高维实,闵军,褚忠华,陈涛,魏菁,区庆嘉.肝癌细胞冻融抗原负载树突状细胞瘤苗的制备与活化[J].中国病理生理杂志,2003,19(9):1279-1282. 被引量:7
  • 6Silke G,Michael S, Herbert R. Dendritic cells pulsed with tumor derived lysate augment T cell mediated tumor cell lysis[J]. Otolaryngol Head Neck Surg, 2004, 131 (2): 176.
  • 7Kono K,Takasha A,Sugai H, et al. Dendritic ceils pulsed with HER-2/neu derived peptides can induce specific cell responses in patient with gastric cancer[J]. Clin Cancer Res,2002,8(11) :3394.
  • 8Nair SK, Morse M, Boczkowski D, et al. Induction of tumor specific cytotoxic T lymphocytes in cacer patients by antologous tumor RNA transfected dendritic cells[J]. Ann Surg,2002,235(4) :540.
  • 9Krieg AM. Mechanism and application of immune stimu- latory CpG oligodeoxynucleotides [J]. Biochem Biophys Acta, 1999,1489 (1) : 107.
  • 10Caux C, Massacrier C, Dubois B, et al. Respective involvement of TGF-βand IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34 + progenitors[J]. J Leukoe Biol, 1999,66(5) :781.

二级参考文献18

  • 1Lanzavecchia A, SaUusto F. Regulation of T cell immunity by dendritic cells[J]. Cell, 2001,106(3) :263 - 266.
  • 2Morse MA, Mosca PJ, Clay TM, et al. Dendritic cell maturation in active immunotherapy strategies[J]. Expert Opin Biol Ther, 2002, 2( 1 ) : 35 - 43.
  • 3Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte macrophage colony - stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha[J]. J Exp Med, 1994,179(4) : 1109 - 1118.
  • 4Morse MA, Zhou I j, Tedder TF, et al. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte- macmphage- colony- stimulating factor, interleukin - 4, and tumor necrosis factor- alpha for use in cancer immunotherapy[J]. Ann Surg,1997, 226(1):6- 16.
  • 5Bachleitner- Hofmann T, Stift A, Friedl J, et al. Stimulation of autologous anfitumor T- cell responses against medullary thyroid carcinoma using tumor lysate- pulsed dendritic cells[J]. J Clin Endocrinol Metab, 2002, 87(3):1098- 1104.
  • 6Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T- cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines[J]. Cancer Res, 2001 ,61(17):6445-6450.
  • 7Kanto T, Hayashi N, Takehara T, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus - infected individuals [ J ]. J Immunol,1999, 162(9) :5584- 5591.
  • 8Son YI,Egawa S,Tatsumi T,et al.A novle bulk culture method for generating mature dendritic cells from mouse bone marrow cells[J].J Immunol Methods,2002,262(12):145.
  • 9Actins H,Davis BR,Kirby JA,et al.Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides:a potential therapeutic regime:for bladder cancer immunotherapy[J].Br J Cancer,2003,89(12):2312.
  • 10Smaroula D,Julius MC,Robert L.Function of CD80 and CD86 on monocyte and stem cell derived dendritic cells[J].Exp Mol Pathol,2003,75:217.

共引文献6

同被引文献28

  • 1Xian-SongWang ZhenSheng You-BingRuan YangGuang Mu-LanYang.CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fIuorouracil in murine hepatoma[J].World Journal of Gastroenterology,2005,11(8):1220-1224. 被引量:5
  • 2颜伟,丁国富,李斌,董燕,李军,和生琦,罗平,周红,庞学利.CpG ODN107增强人脑胶质瘤细胞放射敏感性的研究[J].西南国防医药,2007,17(2):135-138. 被引量:9
  • 3Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation[J]. Nature, 1995, 374(6522): 546-549.
  • 4Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA[J]. Nature, 2000, 408(6813): 740-745.
  • 5Vollmer J, Weeratna R, Payette P, et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities[J]. EurJlmmunol, 2004, 34(1): 251-262.
  • 6Takeshita F. Gursel I, Ishii K J, et al. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor9[J]. Semin Immunol, 2004, 16(1): 17-22.
  • 7Huang B, Zhao J, Unkeless JC, et al. TLR signaling by tumor and immune cells: a double-edged sword[J]. Oncogene, 2008, 27(2): 218-224.
  • 8DavorL, Situmm A, Eterovic D, et al. lmmunoprophylatic lntraresical Application of Bacillus Calmette-Gu/:rin after Transuretural Resection of Superficial Bladlder Cancer[J]. CroatMed J, 2003, 44.. 187-192.
  • 9Meyer JP, Porsad R, Gillatt DA, et al. Use ofbacille calmette-GuA rin in superficial bladder cancer[J]. Postgrad Med J, 2002, 78(922): 449-454.
  • 10Akaza H, KoisoK, Ozono S, et al. A clinical Study of PMCJ-9(Bacillus Calmette-Guerin connaught strain) treatment of superficial Bladder cancer and carcinoma situ of the Bladder[J]. Jpn J Clin Oncol, 2003, 33(8): 382-390.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部